The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
S&P 500, Nasdaq Slip as Oil Jumps on Iran Tensions
Asian Currencies Steady as Markets Await U.S. Inflation Data
US Dollar Near Two-Month Low as Markets Await Inflation Data
Natura Q2 Profit Plunges 92% as Financial Expenses Weigh on Earnings
UK Retail Sales Rise as World Cup and Heatwave Boost Food, Pubs and Clothing
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
3 clinical-grade skincare creams you really shouldn’t buy online
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Oil Prices Rise as Hormuz Reopening Remains Uncertain 



